A detailed history of Price T Rowe Associates Inc transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Price T Rowe Associates Inc holds 35,405 shares of PROK stock, worth $53,461. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,405
Previous 19,194 84.46%
Holding current value
$53,461
Previous $48,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.8 - $2.5 $29,179 - $40,527
16,211 Added 84.46%
35,405 $68,000
Q2 2024

Aug 14, 2024

BUY
$1.44 - $4.2 $12,540 - $36,577
8,709 Added 83.06%
19,194 $48,000
Q4 2023

Feb 14, 2024

BUY
$1.21 - $4.76 $12,686 - $49,908
10,485 New
10,485 $19,000
Q2 2023

Aug 14, 2023

BUY
$9.0 - $13.0 $112,509 - $162,513
12,501 New
12,501 $140,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $92.9M
More about PROK
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.